In recent days, Tesla Motors stock (TSLA) has been climbing and climbing, hitting a high of $58.18 earlier today before closing at a respectable $53.99. The rise comes amid a string of headline-making events – higher-than-expected sales, franchise dealer fights and a new warranty program, to name just three – but under all of the good news lies a potential problem. The Wall Street Journal revealed today that Tesla was served subpoenas from US federal prosecutors over details on the company's trading plan for executives. There has been no hint of wrongdoing, the feds just want information, Reuters reports. A similar subpoena was sent to Cardiovascular Systems, which makes medical implements.
The question is how the executives can trade their shares. Reuters reports that it is fine by Securities and Exchange Commission (SEC) rules for executives to use something called a 10b5-1 plan to trade their own stock, "even when they have access to private information." The subpoena does not seem to have anything to do with questions over whether Tesla CEO Elon Musk's recent "overzealous" Tweet was in any way illegal.
This week, analysts at Longboard Asset Management said they believe Tesla common stock will hit $100 in the next 18 months on the way to $200 per share within five years. In any case, we'll have more information ammunition for the debate when Tesla releases first quarter results May 8th.